Effects of infection and confinement on Parkinson's disease during the COVID-19 pandemic
COVID-19 affects people with Parkinson’s disease in a similar way to the general population, but it may be more serious in cases of advanced diseas...
News from Institute of Neurosciences
Behaviours to prevent anxiety and depression during the pandemic
The pandemic and lockdown caused by COVID-19 have increased symptoms of anxiety and depression in the population. However, according to a major sur...
The challenges of psychological and psychiatric care in the time of COVID-19
Lockdown situations can lead to feelings of stress, frustration, guilt, or even anxiety in the general public. Also, people with mental disorders a...
Biological diagnosis of schizophrenia: the future
Schizophrenia is a very heterogeneous disease, patients who suffer this may present a variety of symptoms. In addition, there is currently no analy...
Early diagnosis of psychosis improves its evolution
Intervention in the early stages of psychosis is fundamental, as delay in the detection and treatment of the first psychotic episode is associated...
Researchers identify a group of genetic markers linked to the start of symptoms of Parkinson’s disease
Researchers from the Institute of Neurosciences of the University of Barcelona (UBNeuro), Hospital Clínic and the IDIBAPS have identified a group o...
Described the role of inflammation in schizophrenia
Several studies have shown that different psychiatric disorders share a common denominator: inflammation forms part of their pathological mechanism.
Increase in stroke cases linked to contamination
Recent studies show that high pollution in the environment increases the risk of having a stroke According to the Spanish Society of Neurology (in...